Allogene Therapeutics, Inc.

ALLO · XNAS

CIK 1737287fmd_09KTA4BYXWMBKHANVDD2V881R6Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2018 to Sep 30, 2026, 35 periods